Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Efficacy and Safety of Empagliflozin (BI 10773) Versus Placebo and Sitagliptin Over 24 Weeks in Patients With Type 2 Diabetes
empagliflozin
1245.20
NCT01177813
Diabetes Mellitus, Type 2
Phase 3
 
December 2014

Powered by ideaPoint, Inc.